top of page
All Posts


Amyotrophic Lateral Sclerosis: The Role of Physiotherapy According to Contemporary Science
Introduction Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons and leading to increasing muscle weakness, loss of functional independence, and respiratory failure. Despite the absence of curative treatment, growing attention is being given to non-pharmacological supportive approaches, among which physiotherapy plays a key role. Contemporary systematic reviews and meta-analyses indicate that physiotherapy in ALS is not only


Multiple Sclerosis: Effectiveness of Physiotherapy and Therapeutic Exercise According to Scientific Evidence
Introduction Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that leads to motor, sensory, and cognitive impairments. Despite significant progress in pharmacological therapy, there is currently no intervention capable of altering the long-term prognosis of the disease. For this reason, physiotherapy and therapeutic exercise are considered key components of symptomatic and supportive care for patients with MS. The aim of this article is to


Parkinson’s Disease: Effectiveness of Physiotherapy According to Contemporary Research
Introduction Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterised by progressive motor impairments, including bradykinesia, rigidity, tremor, gait disturbances, and balance deficits. In addition to pharmacological treatment, physiotherapy plays an important role in patient management, aiming to maintain motor function, independence, and quality of life. Over recent years, a substantial body of scientific evidence has accumulated, including systematic


Dementia: The Effectiveness of Physiotherapy According to Scientific Research
Introduction Dementia is a progressive neurodegenerative condition that leads to cognitive decline, impaired motor function, and loss of independence in daily activities. Despite the widespread use of pharmacological therapy, drug-based treatment has limited effectiveness and does not alter the course of the disease. As a result, increasing attention is being directed toward non-pharmacological approaches, particularly physiotherapy and therapeutic exercise. The aim of this a


Physiotherapy in Diabetic Peripheral Neuropathy: How Effective Is It?
Diabetic peripheral neuropathy (DPN) is one of the most common and severe complications of diabetes mellitus. It manifests as chronic pain, burning sensations, numbness, reduced sensitivity, and impaired limb function, significantly diminishing patients’ quality of life. In the search for non-pharmacological treatment options, increasing attention has been given to physiotherapy, particularly transcutaneous electrical nerve stimulation (TENS) and therapeutic exercise. This ar


The Role and Effectiveness of Physiotherapy in Duchenne Muscular Dystrophy: What Research Shows
Introduction Duchenne muscular dystrophy (DMD) is a severe inherited X-linked disorder characterised by progressive muscle weakness, loss of motor function, and reduced quality of life beginning in early childhood. Despite the absence of etiological treatment, physiotherapy represents a key component of rehabilitation, aimed at slowing functional decline, preventing contractures, and maintaining the highest possible level of patient independence. Goals of Physiotherapy in DMD


The Impact of Physiotherapy and Physical Activity in Autism: What Current Research Shows
Introduction Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects not only communication and social interaction, but also motor development. According to research data, up to 83% of children with ASD experience difficulties in performing age-appropriate motor skills. In recent years, physiotherapy and physical activity have increasingly been considered important components of a comprehensive support approach for children with autism. The aim of this a


Randomized Clinical Trials (RCT) vs Compassionate Use: Key Differences in Modern Medicine
Introduction In modern medical discourse—particularly in the context of advanced, regenerative, and cell-based therapies—two fundamentally different clinical approaches are often confused: randomized clinical trials (RCTs) and compassionate use . Although both play important roles in the development and application of medical innovation, they serve distinct scientific, ethical, and clinical purposes . Understanding this distinction is essential for patients, families, and cl


COPD — Improved Breathing Capacity and Physical Endurance
Clinical Case Observation: Chronic Obstructive Pulmonary Disease (COPD) Patient: Pier Giorgio | Italy Patient Background Pier Giorgio , a man from Italy, has been living with chronic obstructive pulmonary disease (COPD) — a chronic respiratory condition associated with impaired oxygenation, persistent fatigue, cough, and excessive mucus production. Prior to treatment, his condition significantly limited physical activity and daily functioning. At baseline, even moderate exer


Registered Clinical Research on Neuroinflammatory Syndromes (NCT07145502)
BioCells Medical | ClinicalTrials.gov Identifier: NCT07145502 Neuroinflammatory conditions of autoimmune or post-infectious origin represent a complex and often debilitating group of disorders affecting the central nervous system. These syndromes—including autoimmune encephalitis, post-infectious encephalopathies, and neuroinflammatory demyelination—can lead to cognitive impairment, neurological deficits, fatigue, and reduced quality of life. In many patients, standard immuno


Brussels, Belgium — Global Access International On-Site Regenerative Treatment Program
Location: Brussels, Belgium Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Amyotrophic lateral sclerosis (ALS) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Brussels, Belgium , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and structured su


Registered Clinical Research on Progressive Multiple Sclerosis (NCT07146087)
BioCells Medical | ClinicalTrials.gov Identifier: NCT07146087 Multiple sclerosis ( MS ) is a chronic, immune-mediated neurological disorder characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. In its progressive forms — particularly secondary progressive MS (SPMS) and primary progressive MS (PPMS) — the disease leads to accumulating disability, impaired mobility, cognitive decline, fatigue, and decreased quality of life for pa


Vienna, Austria — Global Access International On-Site Regenerative Treatment Program
Location: Vienna, Austria Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Multiple system atrophy (MSA) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Vienna, Austria , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and structured supervision


Marseille, France — Global Access International On-Site Regenerative Treatment Program
Location: Marseille, France Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Chronic obstructive pulmonary disease (COPD) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Marseille, France , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care and stru


Registered Clinical Research on Amyotrophic Lateral Sclerosis (ALS) (NCT07143656)
BioCells Medical | ClinicalTrials.gov Identifier: NCT07143656 Amyotrophic lateral sclerosis ( ALS ) is a progressive neurodegenerative condition that affects motor neurons — the nerve cells responsible for controlling voluntary muscle movement. Over time, ALS leads to muscle weakness, difficulties with speech and swallowing, respiratory decline, and significant impairment in daily functioning. Despite extensive research, there remains an urgent need to better understand how t


Florence, Italy — Global Access International On-Site Regenerative Treatment Program
Location: Florence, Italy Program: Global Access — On-Site Regenerative Treatment Patient: Pediatric patient (identity undisclosed) Diagnosis: Cerebral palsy (CP) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Florence, Italy , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for families seeking advanced medical support while receiving treatment outside


BioCells Medical in NewTimes.kz
Publication: NewTimes.kz Title: “From Multiple Sclerosis to Parkinson’s: more and more people are becoming victims of severe diseases” 📍 In early 2025, the respected outlet NewTimes.kz published a feature on the global rise of neurodegenerative conditions. The article highlighted the role of BioCells Medical as a premium international clinic that applies advanced regenerative medicine to support patients and families facing these diagnoses. 🧬 Science and Innovation a


ALS — regained movements and improved swallowing
Clinical Case Observation: Amyotrophic Lateral Sclerosis (ALS) Patient: Ilaria Baldi, 43 years | Italy Patient Background Ilaria Baldi , a 43-year-old woman from Italy, was diagnosed with amyotrophic lateral sclerosis (ALS) in 2022. The initial presentation involved progressive weakness of the right hand. Over time, the condition led to increasing limitations in both upper and lower limb mobility, accompanied by difficulties with swallowing and reduced bulbar function. By th


Shymkent, Kazakhstan — Global Access International On-Site Regenerative Treatment Program
Location: Shymkent, Kazakhstan Program: Global Access — On-Site Regenerative Treatment Patient: Adult patient (identity undisclosed) Diagnosis: Primary Progressive Multiple Sclerosis (PPMS) Overview As part of the Global Access program, the BioCells Medical medical team traveled to Shymkent, Kazakhstan , to deliver an individualized regenerative treatment protocol directly at the patient’s location. This format is intended for patients who require advanced medical care a


ALS — real improvements and ongoing support
Clinical Case Observation: Amyotrophic Lateral Sclerosis (ALS) Patient: Rebecca | Italy Patient Background Rebecca , a woman from Italy, was diagnosed with amyotrophic lateral sclerosis (ALS) in July 2023. The initial symptoms presented in one lower limb and gradually progressed to involve the upper extremities and speech function, reflecting a typical pattern of disease progression. At the time of presentation at BioCells Medical, the condition was associated with increasin
bottom of page
